Log in to save to my catalogue

Management of Hemoglobin Decrease in Patients Treated With ABT-450/Ritonavir/Ombitasvir and Dasabuvi...

Management of Hemoglobin Decrease in Patients Treated With ABT-450/Ritonavir/Ombitasvir and Dasabuvi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_14309_00000434_201410002_00443

Management of Hemoglobin Decrease in Patients Treated With ABT-450/Ritonavir/Ombitasvir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Patients: 443

About this item

Full title

Management of Hemoglobin Decrease in Patients Treated With ABT-450/Ritonavir/Ombitasvir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Patients: 443

Journal title

The American journal of gastroenterology, 2014-10, Vol.109, p.S133

Language

English

Formats

More information

Alternative Titles

Full title

Management of Hemoglobin Decrease in Patients Treated With ABT-450/Ritonavir/Ombitasvir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Patients: 443

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_14309_00000434_201410002_00443

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_14309_00000434_201410002_00443

Other Identifiers

ISSN

0002-9270

DOI

10.14309/00000434-201410002-00443

How to access this item